Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
NL0012044747
Tue, 15.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology.
Sevenum, the Netherlands, 15 July 2025. Today Redcare Pharmacy was notified by its technology partner eHealth Experts that an extension until 31 January 2027 for its CardLink product license has been recei [ … ]
Tue, 15.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy’s CardLink solution extended by gematik.
Sevenum, 15 July, 2025. Through its technology partner, eHealth Experts, Redcare Pharmacy N.V. today received confirmation that its CardLink solution license for the redemption of e-prescriptions in Germany has been extended by the German National Digital Health Agency (gematik) until 31 Ja [ … ]
Thu, 03.07.2025
Redcare Pharmacy N.V.
Redcare Pharmacy confirms guidance for all elements after strong Q2 performance, with total sales growing 26.4%.
Total sales up 26.4% to EUR 709M in Q2 and 27.2% to EUR 1.4bn in H1.
Non-Rx sales up 17% to EUR 457M in Q2 and 18.3% to EUR 941M in H1. Impact from the shift of Easter from Q1 to Q2 is evened out in the H1 numbers.
Rx sales in Germa [ … ]
Wed, 04.06.2025
Redcare Pharmacy N.V.
Statement on today’s media coverage regarding CardLink.
Today’s publications in the media referred to structural changes in the way e-prescriptions will be redeemed digitally from April 2026. Those publications do not contain any new information. In August 2024, gematik published a technical concept outlining the so-called PoPP solution (Proof of [ … ]
Fri, 16.05.2025
Redcare Pharmacy N.V.
Redcare Pharmacy's Annual General Meeting 2025: All agenda items approved; Michael Köhler and Stephan Weber new members of the Supervisory Board.
Sevenum, the Netherlands, 16 May, 2025. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of M [ … ]
Tue, 06.05.2025
Redcare Pharmacy N.V.
Strong Q1 performance for Redcare Pharmacy: back to a positive margin while maintaining fast growth.
Total sales increased 28% to EUR 717M; non-Rx sales up 20% to EUR 484M, Rx sales in Germany up 191% to EUR 108M.
Adj. EBITDA improved EUR 14M vs. the prior quarter to EUR +9M and the margin from -0.7% to 1.3%; prior year, adj. EBITDA of EUR 12M, ma [ … ]
Tue, 08.04.2025
Redcare Pharmacy N.V.
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL [ … ]
Tue, 08.04.2025
Redcare Pharmacy N.V.
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL [ … ]
Tue, 08.04.2025
Redcare Pharmacy N.V.
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL [ … ]
Fri, 04.04.2025
Redcare Pharmacy N.V.
Redcare Pharmacy: fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million.
Group sales up 28% or EUR 157M year over year, to EUR 717M in Q1.
Rx sales in Germany up 191% to EUR 108M.
Non-Rx sales up 20% to EUR 484M.
Active customer base up 0.6M in Q1 to 13.1M, 1.9M higher in [ … ]
